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A Herpesvirus Encoded Deubiquitinase Is a Novel
Neuroinvasive Determinant
Joy I. Lee1, Patricia J. Sollars2, Scott B. Baver2, Gary E. Pickard2, Mindy Leelawong1, Gregory A. Smith1*
1 Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America, 2 Department of
Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America

Abstract
The neuroinvasive property of several alpha-herpesviruses underlies an uncommon infectious process that includes the
establishment of life-long latent infections in sensory neurons of the peripheral nervous system. Several herpesvirus
proteins are required for replication and dissemination within the nervous system, indicating that exploiting the nervous
system as a niche for productive infection requires a specialized set of functions encoded by the virus. Whether initial entry
into the nervous system from peripheral tissues also requires specialized viral functions is not known. Here we show that a
conserved deubiquitinase domain embedded within a pseudorabies virus structural protein, pUL36, is essential for initial
neural invasion, but is subsequently dispensable for transmission within and between neurons of the mammalian nervous
system. These findings indicate that the deubiquitinase contributes to neurovirulence by participating in a previously
unrecognized initial step in neuroinvasion.
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Recently, an isolate of PRV mutated in a conserved
deubiquitinase (DUB) domain of a viral structural protein, the
pUL36 tegument protein, was reported to infect the nervous
system with delayed kinetics following intranasal inoculation into
mice [13]. In this report, we demonstrate that an isolate of PRV
mutated in a critical catalytic residue of the pUL36 DUB domain
replicates and spreads within the nervous system, but is severely
attenuated in its ability to initially invade the nervous system from
peripheral tissues. Using time-lapse fluorescence microscopy, the
DUB mutant virus was found to transport in axons both following
entry (retrograde transport) and replication (anterograde transport)
in cultured neurons. Furthermore, the DUB mutant replicated and
spread in the nervous system following direct inoculation: either by
injecting mutant virus into the brain or vitreous chamber of the
eye. Unlike previously described neuroinvasive mutant viruses, the
DUB mutant was competent to spread to synaptically-linked
second- and third-order CNS neurons in a manner similar to wildtype infections in both anterograde and retrograde circuitry.
Together, these findings demonstrate that the pUL36 deubiquitinase represents a novel neuroinvasion determinant that functions
at a previously unrecognized initial step in penetration of the
nervous system from peripheral tissues.

Introduction
Neuroinvasive herpesviruses comprise a group of pathogens
with individual members infecting different mammalian hosts.
Four viruses of this group infect humans: herpes simplex virus type
1 (HSV-1), herpes simplex virus type 2 (HSV-2), varicella zoster
virus (VZV) and simian herpes B virus (SHBV). The latter is
associated with rare life-threatening zoonotic infections. Diseases
associated with these viruses range from minor recurrent lesions to
shingles, keratitis and encephalitis. All of these pathologies can
occur as a consequence of viral dissemination into the nervous
system. There are additional neuroinvasive herpesviruses that
infect mammals other than humans. Among these, pseudorabies
virus (PRV) has a broad host range and is commonly associated
with severe encephalitic infections, making it a useful model for
studies of neuroinvasion and pathogenesis [reviewed in 1]. In
addition, the propensity of PRV to transmit neuron-to-neuron
during encephalitic spread has led to its use as a self-amplifying
tracer for mapping of the vertebrate neural circuitry [reviewed in
2]. PRV is closely related to VZV (both are members of the
varicellovirus subgroup of the alpha-herpesvirus family), and
shares a common structure, similar genetic composition and a
related infectious cycle with all neuroinvasive herpesviruses [2,3].
To date, mutant viruses displaying defects in neurotropism fall
into two categories: neuron-specific replication mutants and axon
transport mutants. Mutants of HSV-1 that fail to replicate in neurons
include viruses lacking thymidine kinase activity or ICP34.5 [4–7].
In contrast, HSV or PRV lacking the gE glycoprotein or the Us9
type-II membrane protein replicate in neurons, but subsequently fail
to transport progeny viral particles within axons [8–12].
PLoS Pathogens | www.plospathogens.org

Results
Isolation and initial characterization of the pUL36 mutant
virus
A conserved cysteine residue in the pUL36 tegument protein
that is critical for the proteolytic activity responsible for
1
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Author Summary
Subsets of herpesviruses, such as herpes simplex virus and
pseudorabies virus, are neuroinvasive pathogens. Upon
infection, these viruses efficiently target peripheral nervous system tissue and establish a life-long infection for
which there is no cure. Very few pathogens are known that
invade the nervous system proficiently, and the mechanism by which herpesviruses achieve neuroinvasion is
largely unknown. In this study, we demonstrate that a viral
protease plays a critical and specific role allowing the virus
to cross the threshold of the nervous system, but is
dispensable for subsequent replication and encephalitic
spread within the brain.
deubiquitination [14–18] is also required for efficient invasion of
the central nervous system by PRV [13]. To examine the
neuroinvasive defect further, an alanine substitution (C26A) was
incorporated into an isolate of PRV that also encodes a redfluorescent protein fused to the VP26 capsid protein (Figure 1A).
The mRFP1-VP26 fusion allows for imaging of viral particles in
neurons and does not impact viral propagation in cell culture
[19,20]. The C26A mutation did not have a polar effect on the
upstream expression of the UL37 gene (Figure 1B), unlike a
previously described in-frame deletion that removes the aminoterminal DUB domain from the pUL36 protein [21]. The kinetics
of propagation and cell-to-cell spread of PRV encoding the DUB
C26A mutation were reduced relative to the virus encoding wildtype pUL36, consistent with previous findings that the pUL36
DUB serves an important, but not essential, function in cell culture
(Figure 1C and 1D) [16,21–23].

Neuroinvasion in an eye model of infection
PRV is frequently used as a trans-synaptic neurotracer to map
circuits within the mammalian nervous system [reviewed in 2]. In
particular, neural circuits between the eye and brain have been
extensively studied in rodents infected with PRV, which we used as
the basis for our current studies of the C26A mutant virus [24–33].
Viruses encoding RFP-capsids and either a wild-type pUL36 allele
(PRV-GS847) or the C26A allele of pUL36 (PRV-GS1652) were
injected into the vitreous body of the eye of adult rats to directly
expose retinal ganglion cell (RGC) neurons to the inoculum.
RGCs project axons to visual centers in the brain and provide an
anterograde route for encephalitic spread of the virus. Of the nine
animals infected with wild-type virus, 4 succumbed to infection
between 60-74 hours post infection (hpi); the remaining 5 animals
were killed between 70–72 hpi. The C26A virus was attenuated in
this model with animals showing little ill effect; therefore, animals
were killed 47–264 hpi to examine the extent of viral spread.
Because several attenuated mutants of PRV fail to traverse
anterograde circuits, the brains of infected animals were examined
for capsid fluorescence [10,24,28]. The superior colliculus (SC), a
primary target of RGC efferent axons, contained trans-synaptically labeled neurons in animals infected with either the wild-type
or mutant virus in about 25% of the intravitreally injected animals
(Table 1), which is similar to other wild-type strains of PRV [24].
Because anterograde spread of the C26A mutant of PRV was
unexpected, and did not account for its severe attenuation, the
brains of these animals were also examined for evidence of
infection via retrograde autonomic circuits. Intravitreal injection
into the eye can expose the iris and ciliary body to viral inoculum,
which receive autonomic innervation. The time course of infection
and retrograde spread of PRV in these circuits is somewhat
variable due to the gelatinous matrix of the vitreous body
PLoS Pathogens | www.plospathogens.org

Figure 1. Propagation of PRV with a mutated amino terminus
in cultured cells. (A) Illustration of the PRV-Becker genome with
region encoding the UL36 gene (which encodes the pUL36 protein) and
neighboring UL37 gene expanded. The position of the codon change
resulting in the C26A point mutation is indicated. Promoters are
represented as black triangles. IR, internal repeat. TR, terminal repeat.
(B) Purified extracellular virions encoding mRFP1-capsids and either a
wild-type UL36 allele (WT; PRV-GS847) or UL36 allele encoding the
amino-terminal point mutation (C26A; PRV-GS1652) were examined by
Western blot analysis for the incorporation of the UL37 protein. The
major capsid protein, VP5, was used as a loading control. (C)
Comparison of plaque diameters resulting from infection of Vero cells
with the virus encoding wild-type UL36 (WT) or mutated UL36 (C26A)
allele. Each virus also encodes the mRFP1-VP26 fusion (red capsids).
Error bars are standard error of the means (SEM). (D) Propagation
kinetics of viruses encoding wild-type UL36 (WT), mutated UL36 (C26A),
or a wild-type revertant of the C26A allele (Rev). All viruses also encode
the mRFP1-VP26 fusion (red capsids). Infectious virions were detected
as plaque-forming units harvested from either the cells (cells) or tissue
culture supernatant (sups).
doi:10.1371/journal.ppat.1000387.g001

(compared to the aqueous humor of the anterior chamber, see
below). Nevertheless, in these experiments wild-type virus was
reproducibly observed to have infected the Edinger-Westphal
2
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Table 1. Summary of PRV neuroinvasion by examination of trans-synaptically labeled neurons.

Anterograde (SC)

WT

C26A

Rev (C26)

1:1d

PRV-152

1/5 (20%)

4/15 (27%)

n/d

n/d

n/d

5/5 (100%)

0/15 (0%)c

n/d

n/d

n/d

3/3 (100%)

0/4 (0%)

3/3 (100%)

3/3 (100%)e

4/4 (100%)

n/d

2/2 (100%)

n/d

n/d

n/d

n/d

1/11 (9%)

n/d

n/d

10/11 (91%)

a

Intravitrealb
Retrograde (EW)a
Intravitrealb
Anterior Chamber

b

Retrograde (RGC)a
SCNb
Retrograde (CNS)a
Eyelidb
a

site imaged.
site injected.
one animal showed fluorescence signal in the oculomotor nucleus.
d
1:1 mixture of PRV-152 (Bartha; green fluorescence) and PRV-GS1652 (C26A; red fluorescence).
e
all 3 animals emitted red and green fluorescence in the EW indicative of PRV-152 and PRV-GS1652 co-infection.
SC superior colliculus.
EW Edinger-Westphal nucleus.
RGC retinal ganglion cells.
CNS central nervous system.
WT virus encoding wild-type pUL36.
C26A virus encoding C26A mutant isoform of pUL36.
Rev revertant of C26A virus (encodes wild-type pUL36).
n/d no data.
doi:10.1371/journal.ppat.1000387.t001
b
c

was intact, and suggests the defect observed after intravitreal
injection was likely due to a change in intercellular viral spread in
animals. While these results did not immediately explain the defect
observed in spread through retrograde sympathetic and parasympathetic circuits following intravitreal inoculation (i.e. to the EW

nucleus (EW) of the midbrain, preganglionic parasympathetic
neurons that project to neurons in the ciliary ganglion via the
oculomotor nerve, which in turn innervates the smooth muscles in
the iris and ciliary body in the eye to mediate pupillary constriction
and lens accommodation, respectively. In contrast, capsid
fluorescence was never detected in the EW following C26A virus
infection (Table 1). Wild-type virus also spread to the paraventricular nucleus (PVN) via a retrograde circuit of sympathetic
origin (from iris, to superior cervical ganglion to spinal cord to
paraventricular nucleus). Consistent with an inability to spread in
retrograde circuitry, no labeled cells were observed in the PVN of
C26A virus infected animals (data not shown). However, one
animal that received an intravitreal injection of C26A virus
showed clear signs of retrograde spread to the oculomotor nucleus,
which innervates 4 of the 6 extraocular muscles of the eye (data
not shown). While this result was only observed once, it cannot be
ignored as it indicates that the C26A virus was capable of
spreading from the eye to the brain via a retrograde circuit under
some circumstances. We hypothesized that damage to the sclera
(outer layer of the eye) and attached extraocular muscles resulting
from intravitreal injection may sometimes allow for spread from
the extraocular muscle to the oculomotor nucleus in the brain.
Therefore, further examination of retrograde spread was necessary
to determine the specific defect resulting from the C26A mutation.

The C26A virus is competent to spread in anterograde
and retrograde circuits
To determine if the C26A virus was capable of intracellular
transport in both the retrograde and anterograde directions, we
examined axonal transport in cultured dorsal root sensory neurons
by tracking red-fluorescence emissions from capsid particles by
time-lapse microscopy. In these assays, the C26A virus behaved
similarly to the wild-type virus, having only small decreases in
axon transport during both stages of infection (Figure 2). These
findings demonstrate that intracellular transport of the C26A virus
PLoS Pathogens | www.plospathogens.org

Figure 2. Viral transport dynamics in axons of cultured primary
neurons. (A) Representative example of retrograde transport of an
individual capsid in a dorsal root sensory axon after infection with the
C26A virus, shown as a time-lapse montage. All frames are
1.68610.8 mm. (B) Retrograde transport efficiency measured as frameby-frame velocities of individual capsid particles in axons (as
documented in panel A). (C) Anterograde transport efficiency measured
by accumulation of newly replicated capsids in axons.
doi:10.1371/journal.ppat.1000387.g002
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that C26A virus is capable of multiple rounds of retrograde transsynaptic spread in vivo (from SCN neurons in the brain to RGCs in
the eye to bipolar/amacrine cells in the eye).

and PVN), they were consistent with the one instance of C26A
virus spread to the oculomotor region of the midbrain.
To further examine trans-synaptic retrograde transport in vivo,
stereotaxic injection of virus directly into the brain was employed.
The suprachiasmatic nucleus (SCN), which receives axon
projections from RGCs in the eye [34], was injected with the
C26A virus. Although there is one SCN in each hemisphere of the
brain, and both neighbor each other adjacent to the brain’s
midline, the stereotactic injection procedure allowed for delivery of
virus to the SCN unilaterally. C26A virus infection was prominent
in the injected SCN, and to a lesser extent in the contralateral
SCN. This spread is noteworthy, as the SCN are reciprocally
innervated [34], and viral spread to the neighboring SCN
provided further evidence that the C26A virus was competent to
spread trans-synaptically in the CNS. Examining the retinas of the
SCN-injected animals provided a definitive confirmation of
retrograde transneuronal transmission with the C26A virus: capsid
fluorescence indicative of infected neurons was detected in
neurons in the RGC layer and also in bipolar and/or amacrine
cells (neurons presynaptic to RGCs) located in the inner nuclear
layer of the retina (Figure 3). This finding was consistent with the
studies using cultured neurons, and unambiguously demonstrated

The C26A defect occurs after virus reaches and replicates
in peripheral sites of innervation
The data up to this point indicated that the C26A virus was
incapable of spread in a subset of neural circuits, but the basis for the
selective loss of function could not strictly be attributed to an inability
to transport in either retrograde or anterograde circuitry. Because
the C26A defect was observed only in retrograde circuits innervating
tissues in the anterior chamber of the eye (i.e. iris and ciliary body),
which are less efficiently infected following intravitreal injections,
animals were next injected in the anterior chamber of the eye
directly. This infection route immediately exposes the iris and
neighboring ciliary body to the viral inoculum and provides a more
reliable infection of the EW with all neuroinvasive strains of PRV
examined to date [25]. Consistent with the intravitreal injections, the
C26A virus again failed to spread to the brain; no infection was
noted in the EW or any other area of the brain in all instances
(Figure 4A). In contrast, a revertant of the C26A virus was
unimpaired for spread to the EW (Table 1).

Figure 3. Retrograde transmission following CNS injection. Stereotactic injection route resulting in exposure of viral inoculum to SCN
neurons. RGC ipsilateral projection to the SCN indicates route of viral transmission to the eye. (A) Representative image of virus fluorescence in the
SCN of a coronal brain slice (region imaged is indicated by the doted box in right panel). 3 V, third ventricle. Scale bar = 40 mm. (B) Virus detected in
the eye following retrograde transmission from the SCN is seen as punctate fluorescence in the RGCs of the ganglion cell layer (GCL) and in bipolar/
amacrine cells of the inner nuclear layer (INL) of the retina. The bright fluorescent band near the top of the image is autofluorescence emitted from
the retinal pigmented epithelium (RPE) at the back of the retina, and is not of viral origin. Scale bar = 10 mm.
doi:10.1371/journal.ppat.1000387.g003

PLoS Pathogens | www.plospathogens.org
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Figure 4. Retrograde transmission defect following anterior chamber injection. Anterior chamber injection route resulting in exposure of
viral inoculum to the iris. The route of viral encephalitic spread is indicated: autonomic oculomotor nerve innervation of the iris from the ciliary
ganglion (CG), which in turn receives innervation from parasympathetic neurons of the Edinger-Westphal nucleus (EW) of the midbrain. (A)
Representative coronal images of EW (shown as a dashed box in coronal illustration) following anterior chamber injection or either wild-type or C26A
virus. (B) Co-infection with PRV-152 and the C26A virus. Diffused GFP fluorescence and punctate RFP capsid signals are emitted from PRV-152 and the
C26A viruses, respectively. Scale bars = 10 mm.
doi:10.1371/journal.ppat.1000387.g004

We next considered that the C26A virus typically propagated to
titers 10-fold reduced relative to wild type (Figure 1). Preliminary
studies indicated that the decrease in titer correlated to an increase
in the particle:PFU ratio of the C26A virus, as the C26A virus
produced approximately equal numbers of fluorescent viral
particles as the wild-type virus (data not shown). Therefore, by
concentrating the C26A stocks to attain titers comparable to the
wild-type virus, which were necessary to initiate reproducible
PLoS Pathogens | www.plospathogens.org

infections of the nervous system, defective particles in the
concentrated C26A viral stock may have interfered with infection
of the retrograde circuits. As an initial test for interference, a stock
of wild-type virus (PRV-GS847) was prepared as a concentrated
stock and inoculated into the anterior chamber of the eye.
Although 10-fold more viral particles were inoculated in this
experiment than normal, retrograde transmission to the EW
occurred unabated (data not shown). As a second test for
5
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interference, the C26A virus was mixed with an equal titer of
PRV-152 virus and co-injected into the anterior chamber of the
eye. PRV-152 is a derivative of the PRV-Bartha strain, which is an
attenuated PRV isolate that is incapable of spread in anterograde
circuits but retains spread in all retrograde circuitry [24]. PRV152 encodes a GFP reporter cassette driven by a cytomegalovirus
immediate early promoter, and therefore provides a fluorescent
marker that is distinct both spectrally and spatially from the RFPcapsid emissions of the C26A virus (mRFP1-capsid fluorescence is
most profound in the nucleus of an infected cell, whereas the GFP
signal is diffuse throughout the cell body and neurites of an
infected neuron). If the concentrated stock of C26A virus inhibited
infection of the sympathetic and parasympathetic circuits
innervating the eye, PRV-152 infection of the same circuits
should also be blocked in a co-infection paradigm. However,
interference was never observed and GFP fluorescence indicating
presence of PRV-152 was readily detected in the EW (Figure 4B).
Furthermore, RFP-capsid fluorescence emissions indicative of the
C26A virus were now also detected in the EW of these co-injected
animals.
Spread of C26A virus to the EW in the co-injection experiment
indicated that PRV-152 had complemented the C26A defect. For
complementation to occur, both viruses would have had to
replicate in a common cell prior to entering the nervous system.
This provided an incentive to examine the iris and ciliary body of
the co-injected animals for co-infected cells (Figure 5A and 5B).
Infection of the ciliary body and iris by both PRV-152 and the

C26A virus was frequently observed and areas infected by either
virus often displayed some degree of overlap, indicating that initial
replication in these tissues prior to neuroinvasion provided an
opportunity for the C26A virus to benefit from the unaltered
pUL36 protein expressed by PRV-152 (Figure 5A, and data not
shown). In a subsequent experiment, the C26A virus was found to
infect cells of the iris efficiently when injected alone into the
anterior chamber of the eye (Figure 5C). Therefore, the C26A
virus remained competent to enter and replicate in the iris, but in
the absence of PRV-152 failed to invade the nervous system via
the autonomic innervation of the iris/ciliary body.

The C26A virus is defective for neuroinvasion from
peripheral tissues
To confirm that the C26A virus had a specific defect in
neuroinvasion from tissues innervated by the PNS, PRV-152 and
the C26A virus were independently injected into the skin and
muscle of one eyelid each per animal; the smooth muscle of the
eyelid receives both sympathetic and parasympathetic innervation
[35]. In this infection paradigm, PRV-152 consistently spread to
several regions of the brain. Most notable was transmission to the
locus ceruleus of the caudal pons (Figure 6). The C26A virus failed
to spread to the locus ceruleus, and in fact was entirely absent from
the brain in 10 of 11 animals (Table 1).
To explain how the C26A virus spread retrogradely in one
animal, we again considered the possibility that injection into the

Figure 5. Viral infection in peripheral tissue of the eye. (A) Images of the ciliary body following co-infection with PRV-152 (diffuse GFP signal)
and the C26A virus (punctate RFP signal) in the anterior chamber. Cells infected with both viruses are evident in the merged image. (B) Illustration of
the peripheral tissues in the eye (iris and ciliary body) exposed to viral inoculum and imaged in these studies. (C) C26A virus fluorescence from nuclei
of cells in the iris following anterior chamber injection. Scale bars = 10 mm.
doi:10.1371/journal.ppat.1000387.g005

PLoS Pathogens | www.plospathogens.org
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Figure 6. Retrograde transmission defect following eyelid injection. Example of a single animal injected with PRV-152 and the C26A virus
independently injected in opposing eyelids. Retrograde transmission of PRV-152, but not the C26A virus, to the locus cerulus (LC) is indicated in the
fluorescence images. Region of brain imaged is illustrated as the two dashed boxes in a coronal brain slice (right panel). 4 V, fourth ventricle. Scale
bar = 10 mm.
doi:10.1371/journal.ppat.1000387.g006

eyelid might have caused local tissue damage that allowed direct
exposure of the inoculum to innervating axon projections. We expect
that a similar event likely occurred in the one intravitreal injected
animal in which C26A virus spread specifically to the oculomotor
nucleus (see above). To determine if injection can, in some instances,
allow for direct exposure of the inoculum to axons embedded within
the peripheral tissue, the beta subunit of cholera toxin (CTB)
conjugated to Alexa Fluor 594 was injected into the eyelid. CTB is a
retrograde tracer, but unlike neuroinvasive herpesviruses which
spread trans-synaptically, CTB labeling is restricted to the neuron
cell body from which an axon projects. Furthermore, CTB must
come into direct contact with the axon to label the distal neuronal
cell body. Of 6 animals tested, only one showed CTB retrograde
label into the brain. The absence of CNS labeling in the remaining
five animals indicated that injection into the eyelid infrequently
allowed for direct exposure to nerve endings. This finding was
consistent with the conclusion that the C26A virus is specifically
incapable of invading the mammalian nervous system from tissues
innervated by the PNS, except in infrequent cases when nerve
endings become directly exposed to the inoculum.

requires the DUB to efficiently invade the nervous system
following intranasal inoculation in mice [13]. Because the
underlying deficiencies that produce these fundamental losses in
pathogenesis are not understood, we sought to explore the PRV
neuroinvasive defect in greater detail. Although the DUB activity
in PRV has yet to be studied enzymatically, the conservation of the
DUB activity throughout all three branches of the herpesviridae
indicates that the DUB is important for the pathogenesis of these
viruses [14–17,23].
Our initial experiments produced results consistent with a
selective loss of retrograde trafficking in the nervous system;
however, retrograde transport of the C26A virus was unmasked by
either infecting neurons directly in the retina or brain, or
presumably by mechanical damage at the site of injection. An
important insight was fortuitously made when the C26A mutant
was co-infected with a virus encoding a wild-type pUL36 protein
(PRV-Bartha), resulting in the rescue of the C26A defect and
retrograde spread to the brain. This trans-complementation could
only occur if the C26A virus remained competent to infect cells
prior to neuroinvasion, which was subsequently confirmed by
examining the eye for infection. Therefore, the C26A mutation
resulted in a virus that replicated in non-neuronal cells both in
culture and in the iris, and also replicated and spread in cultured
neurons and neural circuits in vivo, but largely failed to spread
between the innervated non-neuronal tissue and the innervating
neurons. Such a defect has never been observed for a
neuroinvasive herpesvirus before, and reveals that a previously
unrecognized barrier to viral dissemination into the nervous
system is overcome by the amino-terminal deubiquitinase domain
embedded in the pUL36 protein. The neuroinvasion defect was
rescued by either co-infection with a virus encoding a wild-type
pUL36 protein or by repairing the C26A mutation directly,
confirming that the neuroinvasive defect mapped to the pUL36encoded DUB.
In contrast to the results presented here, a previous study that
examined the role of the PRV DUB following intranasal infection
reported only a general delay in neuroinvasion [13]. This apparent
discrepancy can be explained by findings made with a replicationdefective mutant of herpes simplex virus type 2 (HSV-2), a
neuroinvasive herpesvirus related to PRV. Although a replicationdefective virus cannot propagate and spread infection cell to cell,
the HSV-2 replication-defective mutant nevertheless infected the

Discussion
Since its discovery four years ago [14], the herpesvirus pUL36
deubiquitinase has been the focus of several reports due to its
potential as a target for the development of novel antiviral
compounds. The DUB is conserved in all herpesviruses so far
examined, and enzymatic assays are available to aid in screens for
small molecule inhibitors [15,36]. However, little is known
regarding the role of the DUB in the herpesvirus infectious cycle
and its significance to productive infection, and substrates of the
DUB during infection have yet to be identified. Surprisingly, the
DUB is one of the few domains of the large pUL36 tegument
protein (an essential herpesvirus structural component) that is
dispensable for herpesvirus propagation in cultured cells. Although
mutation of the DUB in several herpesviruses reduces viral
propagation kinetics, the underlying defect associated with these
mutants in cultured cells is unclear [16,21–23]. Initial studies of
DUB-mutant herpesviruses in animal models have revealed more
substantial defects. MDV, a herpesvirus noted for its oncogenic
activity, requires the DUB to produce tumors in chickens [23].
The neuroinvasive herpesvirus studied in this report, PRV,
PLoS Pathogens | www.plospathogens.org
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previously made to encode an mRFP1-VP26 (red-fluorescent
capsid) fusion allele (pGS847) [20,53]. A mutant derivative of
pGS847 encoding a single codon change in the UL36 gene (C26A)
was constructed using a two-step RED recombination protocol [54].
The primers used for this protocol were 59- TCAGTATGACCCCGACCTGGGGCCCGGGTCGGGCGTCTCGGCTCTGCGCTCCTCCCTCTCCTTAGGATGACGACGATAAGTAGGG
and 59- TCGTGAAGACCAGGCGCAGGAAGGAGAGGGAGGAGCGCAGAGCCGAGACGCCCGACCCGGGCCCAACCAATTAACCAATTCTGATTAG. The primers encode the
sequence to be mutated (bold) with surrounding homology to the
UL36 gene, as well as homology to the pEPkan-S template plasmid
(underlined). Transfection of the resultant infectious clone,
pGS1652, into pig kidney epithelial (PK15) cells produced the
PRV-GS1652 virus, which typically propagated to a titer of 16107
plaque forming units (PFU) per ml. A revertant virus, PRV-GS1768,
was constructed using the same methods. The primers used were 59TCAGTATGACCCCGACCTGGGGCCCGGGTCGGGCGTCTCGTGCCTGCGCTCCTCCCTCTCCTTAGGATGACGACGATAAGTAGGG and 59- TCGTGAAGACCAGGCGCAGGAAGGAGAGGGAGGAGCGCAGGCACGAGACGCCCGACCCGGGCCCAACCAATTAACCAATTCTGATTAG.
All
mutations were confirmed by restriction digest analysis and
sequencing.
PRV152 is a derivative of the PRV-Bartha vaccine strain that
encodes a GFP-expression cassette driven by the CMV immediate
early promoter inserted in the gG locus, and was described
previously [33]. PRV152 spreads through retrograde circuits
efficiently, and served as a control for these studies.

nervous system following intranasal inoculation in mice, although
not as efficiently as wild-type HSV-2 [37]. Because the same HSV2 mutant was not detected in the nervous system following
intradermal or intramuscular inoculation, these findings indicate
that neurons are directly exposed to viral inoculum in the nasal
cavity. Therefore, neuroinvasive defects can be partially obscured
by a low level of direct neuron exposure in intranasal infection
models, which likely explains the previous PRV findings [13].
Direct exposure of neurons was also occasionally a complication in
our eye and eyelid injection paradigms but in these instances was
presumably a result of tissue damage from the injection procedure,
which is consistent with cholera toxin sporadically labeling
neurons following injection of some animals.
Identification of the molecular determinants that promote the
neuroinvasive behavior of this class of herpesviruses not only
provides insight into the underlying mechanisms of viral dissemination within host tissues, but also into the relationship between tissue
tropism and pathogenesis. Yet, the majority of herpesviruses are not
neuroinvasive pathogens, which argues that the pUL36 DUB may
perform a more fundamental role during infection. Infection of
cultured cells with DUB-mutant herpesviruses has revealed delays in
viral assembly, propagation kinetics and cell-cell spread [13,16,23];
however, how these generalized defects relate to the specific
phenotype seen in animals reported here is unclear. One possible
role for the DUB is cell-to-cell transmission of infection. All
herpesviruses are noted for their ability to establish latent infections
in cell types other than those first exposed to the virus during natural
infections. For example, Epstein-Barr virus first infects epithelial cells
in lymphoepithelial structures such as the tonsils, and then spreads to
B-lymphocytes where latency is established. The general propensity
of herpesviruses to transfer from one cell type to another across
presumably specialized regions of cell-cell contact may have an
underlying requirement for the deubiquitinase activity of pUL36.
Because pUL36 is a cytosolic protein, a possible mode of action
would be to promote newly assembled intracellular virions to exit
cells at sites of cell-cell contact that would otherwise be obscured
from the virus. We expect that 2-chamber models will allow further
examination of the DUB mutant in epithelia-neuron transmission in
culture; however, this will require developing a system where
neurites can be effectively excluded from exposure to the initial viral
inoculum [8,38–42].
The pUL36 tegument protein is greater than 300 kDa in
neuroinvasive herpesviruses such as HSV and PRV, with the
amino-terminal DUB amounting to less than 1/10th of the
protein’s mass. In addition to pUL36 being a critical component of
the herpesvirus structure that links the capsid to the tegument and
envelope layers of the virion [43–48], pUL36 is also implicated in
several stages of the infectious cycle. These stages include: delivery
of viral DNA into the nucleus [49–51], capsid egress from nuclei
[52], capsid microtubule-based transport [52], and virion assembly
and egress from cells [45,46]. Although the DUB could be
fortuitously embedded in the pUL36 protein, it will be of interest
to determine if there is more than just a casual link between
neuroinvasion and other pUL36 functions. Understanding the
mode of action of the pUL36 amino terminus, and identifying
natural cellular and viral substrates for the deubiquitinase
enzymatic activity will be essential to resolving how herpesviruses
spread in animals and cause disease.

Preparation of viral stocks and western blot analysis
Stocks of PRV-GS847 (WT), PRV-GS1652 (C26A), PRVGS1768 (revertant) and PRV152 (Bartha-GFP) were harvested
from infected PK15 cells grown in DMEM supplemented with 2%
bovine growth supplement (Invitrogen). High titer virus stocks
were prepared for a subset of animal studies as described
previously [21]. For Western blot analysis of viral protein
incorporation into extracellular virions, virions were purified from
infected cell supernatants by rate zonal ultracentrifugation in a 12–
32% dextran gradient as described previously [55]. The VP5
capsid protein was detected with mouse monoclonal antibody
3C10 (a gift from Lynn Enquist) at a dilution of 1:1000 and the
UL37 tegument protein was detected with rabbit polyclonal
antibody D1789 at a dilution of 1:2500, as described previously
[56].

Viral propagation kinetics, titers, and plaque size analysis
Quantitation of viral propagation kinetics by single-step growth
curve analysis was conducted as previously described, with the
exception that Vero cells were substituted for PK15 cells [57].
Vero cells were infected at a multiplicity of infection (MOI) of 5 for
each viral strain. Viral titers from cells or media supernatants
harvested at 2, 5, 8, 12 or 24 hours post infection (hpi) were
determined in duplicate by plaque assay. Plaques were counted
following infection of cells in 6-well trays with serial 10-fold
dilutions for each harvested sample. The diameters of these
plaques were also measured from images captured with a 106
objective with a 0.3 numerical aperture (NA). Two orthogonal
diameter measurements of each fluorescent plaque were analyzed
using the Metamorph software package (Molecular Devices). The
reported plaque diameters represent an averaged of more than 50
plaques per virus, and were plotted using the Prism software
package (GraphPad Software).

Materials and Methods
Viruses
Two recombinant viruses were made from a derivative of the
PRV (Becker strain) infectious clone, pBecker3, which was
PLoS Pathogens | www.plospathogens.org
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2 ml of PRV-GS1652 (1–4.256108 pfu/ml) and the upper eyelid
of the other eye was injected with 2 ml of PRV152 (16108 pfu/
ml). In a separate set of experiments, animals received a unilateral
upper eyelid injection of 2 ml of cholera toxin B subunit
conjugated to Alexa Fluor 594 (Molecular Probes, Eugene, OR)
using a Nanoject II nanoinjector fitted with a glass micropipette
(Drummond Scientific Co, Broomall, PA).

Live-cell fluorescence microscopy
Imaging of entry and egress axonal transport events was
performed using primary cultured neurons from embryonic
chicken (E8–E10) dorsal root ganglia, as previously described
[21]. Metamorph and Prism software packages were used for the
analysis of instantaneous velocities and quantitation of viral
capsids in axons. Time-lapse images were captured using an
inverted wide-field Nikon Eclipse TE2000-U microscope fitted
with a 606/1.4 NA objective and a Cascade:650 charge-coupled
device (Roper Scientific). The microscope was housed in a 37uC
environmental box (Life Imaging Services).

Tissue preparation
After post-injection intervals ranging from 2–11 days, animals
were deeply anesthetized with sodium pentobarbital (80 mg/kg,
i.p.), and perfused transcardially with 0.9% saline followed by
freshly prepared fixative consisting of 4% paraformaldehyde in
phosphate buffer (0.1 M), pH 7.3. Brains were removed, stored in
the same fixative containing 30% sucrose at 4uC overnight, and
sectioned at 40 mm in the coronal plane on a sliding microtome
equipped with a freezing stage (Physitemp Instruments Inc.,
Clifton, NJ). Sections were collected in phosphate buffer, mounted
on subbed slides, blotted to remove excess buffer, and coverslipped
with Vectashield mounting medium (Vector Laboratories, Burlingame, CA). Coverslips were sealed with fingernail polish to
prevent dehydration, and slides were stored in the dark at 4uC.
EGFP and mRFP1 fluorescence is stable under these conditions
for several months with minimal quenching. Slides were examined
using a Leica (Nussloch, Germany) DMRA light microscope
equipped with epifluorescence and fitted with a microstepping
servomotor in the z–axis. Images were captured using a
Hamamatsu (Hamamatsu City, Japan) C4742-95 CCD digital
camera under epifluorescence using either EGFP optics (412020
High Q narrow band EGFP filter; Chroma, Brattleboro, VT) or
mRFP optics (#41004 HQ Texas Red filter, Chroma) and
deconvolved using Openlab fluorescence deconvolution software
(Improvision, Boston, MA) running on an Apple Macintosh G4
platform. Digital images were pseudo-colored, and images were
prepared using Adobe Photoshop version 6.0.1. Images were
enhanced for brightness and contrast.

Animals
Male Sprague-Dawley and Long Evans rats (Charles River
Breeding Laboratories) were maintained under a light/dark cycle
of 12 h light/12 h dark with food and water available ad libitum.
Animals were at least 14 weeks of age when used in experiments.

In vivo injection of virus
Intraocular
injections. Under
isoflurane
inhalation
anesthetic (2.5–5%), animals received a unilateral intravitreal
injection of 2 ml of either PRV-GS847 or PRV-GS1652 (1–
14.56108 plaque-forming units/ml) or a unilateral anterior
chamber injection of the same quantity of PRV-GS847, PRVGS1652, PRV152 or a 1:1 mixture of PRV-GS1652:PRV152, over
a 1-min interval using a Nanoject II nanoinjector fitted with a glass
micropipette (Drummond Scientific Co, Broomall, PA). A fresh stock
of virus was thawed for each injection. Animals were maintained in a
biosafety level 2 facility for up to 11 days post-inoculation.
Intracranial injections. Under isoflurane inhalation
anesthetic (2.5–5%), animals were positioned in a Kopf
stereotaxic apparatus (David Kopf Instruments, Tujunga, CA). A
craniotomy was performed, the dura was exposed and a zero depth
reading was made prior to the dura mater being excised. A glass
micropipette attached to a Nanoject II nanoinjector (Drummond
Scientific Co, Broomall, PA), angled laterally 10u to the vertical to
avoid the midline third ventricle, was lowered into the hypothalamus
to a region slightly dorsal to the suprachiasmatic nucleus (SCN) using
coordinates determined empirically in test subjects. The
micropipette was lowered 7.7–7.8 mm from the dura mater, thus
avoiding involvement of the retinal axons in the optic chiasm, and
approximately 200 nl (the Nanoject II was set to the 207 nl volume
preset) of a 16108 pfu/ml stock of PRV-GS1652 were ejected into
the hypothalamic neuropil. The micropipette was left in place for
about 1 minute before slowing retracting, and the craniotomy was
packed with gelfoam and the incision was sutured.
Eyelid injections. Under isoflurane inhalation anesthetic
(2.5–5%), the skin of the upper eyelid of one eye was injected with
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